Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vicore Pharma Holding

8.88 SEK-3.16 %22/10 17:29
Less than 1K followers

VICO

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-3.16 %
-12.43 %
-22.51 %
-13.45 %
-21.42 %
-22.78 %
-35.91 %
-51.35 %
+75.84 %

Vicore Pharma Holding operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.

Read more
Market cap
2.5B SEK
Turnover
8.78M SEK
Revenue
3.82M
EBIT %
-11,851.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
5/11
2026

Interim report Q3'26

25/2
2027

Annual report '26

All
Webcasts
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-10-22 18:50

Vicores fas 2b-studie ASPIRE med buloxibutid vid IPF passerar planerad futilitetsanalys och topline-resultat väntas i mitten av 2027

Vicore Pharma Holding
Regulatory press release2026-10-22 18:50

Vicore’s Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results

Vicore Pharma Holding
Press release2026-10-13 08:00

Vicore Pharma deltar på Chardan Healthcare Conference

Vicore Pharma Holding

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2026-10-13 08:00

Vicore Pharma to Participate in the Chardan Healthcare Conference

Vicore Pharma Holding
Regulatory press release2026-09-30 09:00

Ökning av antalet aktier och röster i Vicore Pharma

Vicore Pharma Holding
Regulatory press release2026-09-30 09:00

Increase in number of shares and votes in Vicore Pharma

Vicore Pharma Holding
Press release2026-09-17 08:00

Vicore Pharma presenterar på Stifel 2026 Virtual Immunology and Inflammation Forum

Vicore Pharma Holding
Press release2026-09-17 08:00

Vicore Pharma to Present in the Stifel 2026 Virtual Immunology and Inflammation Forum

Vicore Pharma Holding
Press release2026-09-01 08:00

Vicore Pharma presenterar vid kommande investerarkonferenser

Vicore Pharma Holding
Press release2026-09-01 08:00

Vicore Pharma to Participate in Upcoming Healthcare Conferences

Vicore Pharma Holding
Press release2026-08-26 08:00

Vicore Pharma presenterar på Pareto Securities 17th Annual Healthcare Conference

Vicore Pharma Holding
Press release2026-08-26 08:00

Vicore Pharma to Present at the Pareto Securities 17th Annual Healthcare Conference

Vicore Pharma Holding
Press release2026-08-24 08:00

Vicore Pharma presenterar på European Respiratory Society Congress 2026

Vicore Pharma Holding
Press release2026-08-24 08:00

Vicore Pharma to Present at the European Respiratory Society Congress 2026

Vicore Pharma Holding
Regulatory press release2026-08-21 08:00

Delårsrapport april-juni 2026

Vicore Pharma Holding
Regulatory press release2026-08-21 08:00

Interim Report April – June 2026

Vicore Pharma Holding
Press release2026-07-07 08:00

Vicore Pharma deltar på Leerink Therapeutics Forum

Vicore Pharma Holding
Press release2026-07-07 08:00

Vicore Pharma to Participate in the Leerink Therapeutics Forum

Vicore Pharma Holding
Press release2026-07-06 08:00

Vicore Pharma utser Rob Slack till Chief Scientific Officer

Vicore Pharma Holding
Press release2026-07-06 08:00

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Vicore Pharma Holding